Insiders · OKUR

Alejandro Dorenbaum

Officer at Reneo Pharmaceuticals, Inc. (OKUR)

Alejandro Dorenbaum has filed 2 insider reports with the SEC since December 2021, as officer at Reneo Pharmaceuticals, Inc. (OKUR). The latest filing, on December 13, 2022, reports grant or award and gift at Reneo Pharmaceuticals, Inc. (OKUR).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Alejandro Dorenbaum is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Reneo Pharmaceuticals, Inc. logo
OKUR
Reneo Pharmaceuticals, Inc.
Officer30,000$2.70Dec 13, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Alejandro Dorenbaum with

Other insiders at the same companies

Questions about Alejandro Dorenbaum

What is Alejandro Dorenbaum's role at Reneo Pharmaceuticals, Inc.?
Alejandro Dorenbaum reports to the SEC as officer at Reneo Pharmaceuticals, Inc. (OKUR), according to the latest filing on December 13, 2022.
How many shares does Alejandro Dorenbaum own?
After the latest filing that states it, Alejandro Dorenbaum directly owned 30,000 shares of Reneo Pharmaceuticals, Inc. (OKUR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Alejandro Dorenbaum bought or sold stock recently?
No open-market purchases or sales by Alejandro Dorenbaum are on file. The filings report grant or award and gift.
How do I get alerts when Alejandro Dorenbaum files?
Follow Alejandro Dorenbaum on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Alejandro Dorenbaum (SEC CIK 0001606083). Totals count each trade once, skipping amendments whose original is on file, from Dec 14, 2021 on. View on SEC EDGAR · Get this as JSON